ActiveNANCT04624646

Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke - The Comparison Between Short-term Continuous Patch and Long-term Discontinuous Monitoring

Sponsor: Ewha Womans University Mokdong Hospital

Trial Details

Condition	Atrial Fibrillation, Ischemic Stroke, Transient Ischemic Attack
Intervention	Discontinuous monitoring; Continuous single-lead ECG Patch; 24-hour Holter monitoring
Phase	NA
Status	Active
Participants	337
Est. Completion	1 Nov 2025
Last Updated	20 May 2026

Primary Outcome

Atrial fibrillation detection rate

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Newly diagnosed brain infarction * No history and diagnosis of atrial fibrillation at the time of admission * Rejected implantable loop recorder * Informed consent Exclusion Criteria: * Cannot use KardiaMobile system alone or with the help of others

Trial Sites

Countries

South Korea

View Registry Entry

Related Analysis

Cryptogenic Stroke Trial Compares Wearable AF Detection Methods — Implications for Secondary Prevention

Korean study compares wearable ECG devices with standard Holter monitoring for detecting occult atrial fibrillation in cryptogenic stroke patients. Results could reshape post-stroke cardiac screening protocols globally.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service